Manchester City were beaten at Newcastle at the weekend but have won three out of four undefeated Champions League games this ...

FRANKFURT (Reuters) -Shares in Bayer jumped more than 8% on Monday after initial clinical trial results turned around the ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.

The Chinese e-commerce leader said its Qwen artificial-intelligence app drew more than 10 million downloads i ...

German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a ...

The fifth round of matches in the 2025-26 Champions League group phase will see Manchester City welcome Bayer Leverkusen to ...

Find out everything you need to know ahead of City's Champions League encounter with Bayer Leverkusen.WHEN AND WHEREWe host ...

Bayer's successful trial comes after it previously halted a phase 3 clinical trial testing the effectiveness of the same experimental drug for stroke and systemic embolism prevention in 2023. At the ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...

Bayer shares surge after its asundexian stroke drug shows positive Phase III results, offering a key boost to its pipeline ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes ...

Investing.com -- Bayer’s (ETR:BAYGN) experimental stroke drug could generate €3 billion in annual sales after successful trial results that Goldman Sachs analyst James Quigley called "transformational ...